Last update 08 May 2025

C-4-29

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
Target
BCMA x CD70
Action
inhibitors
Mechanism
BCMA inhibitors(B-cell maturation protein inhibitors), CD70 inhibitors(CD70 antigen inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [3]
Active Indication
Renal Cell CarcinomaRefractory Multiple MyelomaRelapse multiple myeloma
Inactive Indication-
Originator Organization
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
Active Organization
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with C-4-29
CTR20210564
/ RecruitingPhase 1
嵌合抗原受体T淋巴细胞（C-4-29）细胞制剂治疗复发/难治性多发性骨髓瘤的I期临床研究
[Translation] Phase I clinical study of chimeric antigen receptor T lymphocyte (C-4-29) cell preparations in the treatment of relapsed/refractory multiple myeloma
NCT04861480
/ Enrolling by invitationPhase 1
Phase I Clinical Study of CAR-T Cells (C-4-29) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
100 Clinical Results associated with C-4-29
Login to view more data
100 Translational Medicine associated with C-4-29
Login to view more data
100 Patents (Medical) associated with C-4-29
Login to view more data
100 Deals associated with C-4-29
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Renal Cell CarcinomaPhase 1
China
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
22 Aug 2022
Refractory Multiple MyelomaPhase 1
China
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
16 Jun 2021
Relapse multiple myelomaPhase 1
China
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
16 Jun 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free